Company ValiRx Plc London S.E.
Equities
GB00B23N9136
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- GBX | - |
|
07-03 | EXECUTIVE CHANGES: Jadestone Energy's CFO Bert-Jaap Dijkstra to leave | AN |
06-19 | ValiRx Chairman Resigns | MT |
Business Summary
Sales per Business
GBP in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Drug Development
100.0
%
| 0 | nan % | 0 | 100.0 % | - |
Sales per region
GBP in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United Kingdom
100.0
%
| 0 | nan % | 0 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Suzanne Dilly
CEO | Chief Executive Officer | 46 | - |
Gerald Desler
DFI | Director of Finance/CFO | 79 | 31/08/06 |
Chief Tech/Sci/R&D Officer | - | 07/09/22 | |
Kumar Nawani
COO | Chief Operating Officer | - | - |
Mark Treharne
PRN | Corporate Officer/Principal | - | 30/09/20 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Gerald Desler
DFI | Director of Finance/CFO | 79 | 31/08/06 |
Director/Board Member | 57 | 04-21 | |
Suzanne Dilly
CEO | Chief Executive Officer | 46 | - |
Director/Board Member | 46 | 04-21 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 132,348,673 | 110,065,233 ( 83.16 %) | 0 | 83.16 % |
Company contact information
![address ValiRx Plc](https://cdn.zonebourse.com/static/address/4007309.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+20.17% | 126B | |
+24.67% | 118B | |
+25.44% | 27.87B | |
-17.74% | 20.95B | |
-15.17% | 16.92B | |
-15.21% | 16.18B | |
+11.91% | 14.84B | |
-47.10% | 14.79B | |
+54.50% | 14.08B |
- Stock Market
- Equities
- VAL Stock
- Stock
- Company ValiRx Plc